INS and type 2 diabetes mellitus: As the CBD vasorelaxant responses were blunted in patients with type-2 diabetes, we carried out RT-PCR in human aortic endothelial cells (HAECs) to establish the effects of a high glucose (25 mM) or high insulin (500 nM) environment on the expression of the relevant target sites at the RNA level.